China Origin raw material AHKCU Powder AHK-CU Raw Materials
TDS 10 Inquiries
682809-81-0
Pharmaceutical Grade
99.87%
HONGKONG
Customization Available
1mg*10vials/box,100mg*10vials/box
2026-08-06
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500
-
Product Description
-
Seller Information
-
History Price
-
Inquiry History
-
DescriptionAHK-Cu, also known as Alanine-Histidine-Lysine-Copper, is a synthetic peptide that has garnered significant attention in recent years due to its potential applications in various fields, particularly in dermatology and regenerative medicine. Peptides are short chains of amino acids, and when combined with copper ions, they can exhibit unique biological activities.Certificates
-
TDS
Basic Info-
Product Name:
AHK-Cu
Other Name:ALA-HIS-LYS-CU;Copper Peptide 1:1;L-Alanyl-κN-L-histidyl-κN,κN3-L-lysinato(2-)]copper Monohydrochloride;AHK-Cu(2:1);ALA-HIS-LYS-CU(AHK-Cu);ACETYILHEXAPEPTIDE-8
CAS No.:682809-81-0
Molecular Formula:C15H24ClCuN6O4
InChIKeys:ZVDTZHLNTORZAU-FBSJPIKRNA-L
Molecular Weight:451.39
Categories:
Research-
Class:
Actin-sequestering protein / 43-amino-acid peptide
Status:Research compound — Not FDA approved (investigational: RGN-259 for dry eye / neurotrophic keratitis)
Mechanism:A naturally occurring 43-amino-acid peptide (Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH) that binds G-actin (sequesters monomeric actin), preventing F-actin polymerization. Promotes cell migration, angiogenesis, wound healing, and anti-inflammatory responses via integrin-linked kinase (ILK) and HIF-1α/VEGF pathways. TB-500 is the synthetic fragment Ac-LKKTETQ (MW ~895) often sold under this CAS.
Activity note:Thymosin Beta-4 is an actin-binding protein, not a receptor agonist. Functional activity is measured by actin sequestration (Kd ~0.7–1 μM) and cell migration assays, not EC₅₀.
Source:Goldstein AL, et al. Vitam Horm. 2003;66:257–296. RegeneRx RGN-259 clinical program.DOI
Clinical Development:
References-
DrugBank:PubChem:UNII:Disclaimer:
Thymosin Beta-4 (TB-500) is NOT FDA-approved for human therapeutic use. RGN-259 (Tβ4 ophthalmic solution) is an investigational drug not yet approved. TB-500 sold on research-chemical marketplaces is a synthetic fragment and is not an approved medicine. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500
-
Location:
Room 11B, Building 0056, No. 81-1 Nonglinxia Road, Yuexiu District, Guangzhou City, Guangdong Province
-
Payment Terms:
100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Weekly Price
The chart shows the price trend of the product in the past 12 months.
-
Inquiry History10 Inquiries
Country Product Purchase Quantity Date Posted
United States
AHK-Cu Directly Supply Bottom Price CAS 682809-81-0 Cosmetic Copper Peptide ghk-cu
1 MT Feb 5, 2026
United States
AHK-Cu
10 PCS Jul 16, 2026
United States
Ahk-cu
20 MT Jun 14, 2026
United States
Ahk-cu
100 MT Apr 24, 2026
United States
AHK-cu
1 MT Mar 17, 2026
United States
AHK cu
1 KG Dec 15, 2025
United States
Ahk-cu
1 MT Nov 8, 2025
United States
AHK-CU
20 G Jun 29, 2026
United States
AHK-Cu
1 KG Nov 6, 2025
Sweden
GHK-Cu
1 KG Mar 17, 2026 Post an enquiry for this product